register

News & Trends - MedTech & Diagnostics

MedTech industry collaboration on PPE supply plays key role in elective surgery resumption

Health Industry Hub | April 22, 2020 |

MedTech News: MTAA (Medical Technology Association of Australia) has welcomed Prime Minister Scott Morrison’s announcement that there will be a gradual return to elective surgery starting from next week.

“MTAA has been working closely with the Government to help secure the PPE supplies required to ensure the smooth running of our healthcare system, and we are proud to have played an important role in enabling a return to elective surgery,” said MTAA CEO Ian Burgess.

MTAA’s industry working groups have also been instrumental in securing essential supplies of ventilators and test kits on behalf of the Australian Government.

“The medical technology industry welcomes the announcement that patients will once again have access to life-changing treatments and technology through elective surgery,” said Mr Burgess.

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

The first phase of the reintroduction will occur on 27 April. The selection of patients to undergo elective surgery will include:

  • Procedures representing low risk, high value care as determined by specialist societies
  • Selection of patients who are at low risk of post-operative deterioration
  • Children whose procedures have exceeded clinical wait times
  • Assisted reproduction (IVF)
  • Endoscopic procedures
  • Screening programs
  • Critical dental procedures.

This first stage of reinstating elective surgeries will require health administrators to monitor supplies of personal protective equipment (PPE), ICU and bed capacity, while preparing for the next phase.

On the advice of Australian Health Protection Principal Committee (AHPPC), in addition to Category 1 elective surgeries, hospitals will initially recommence one in four closed operating lists, with a focus on Category 2 and some important Category 3.

“We congratulate Health Minister Greg Hunt and the Morrison Government for taking swift and decisive action to successfully flatten the curve through the elective surgery pause and many other effective measures.

“For a range of medical conditions, what is now non-essential, very quickly becomes essential if left untreated, and a measured and responsible return to elective surgery will ensure continuity of care for those who need it most.

“A gradual and responsible return to elective surgery with the safety of patients and medical personnel front and centre will enable thousands of Australians to access the treatments they need to keep them working, studying and spending more time with their families.

“We look forward to more Australians once again being able to access the life-changing benefits of medical technology,” Mr Burgess said.

You may also like Roche to launch new serology test to detect COVID-19 antibodies


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.